A workshop on making sense of research results and statistics to improve underwriting. AAIM 2015 Mike Fulks

Size: px
Start display at page:

Download "A workshop on making sense of research results and statistics to improve underwriting. AAIM 2015 Mike Fulks"

Transcription

1 A workshop on making sense of research results and statistics to improve underwriting AAIM 2015 Mike Fulks

2 Industry rating approaches Table rating (relative risk) Multiple of expected risk (which is the risk for all standard and preferred insureds together). Expressed as debits (often units of +25%)such as 50 (or total risk of 150% or 2 tables) or as credits such as 25. will be today s focus using laboratory test and physical measurements research Flat extra (absolute extra risk) Increase in risk expressed in $/$1,000 of face amount extra deaths/1,000 lives/yr. Used when extra risk in deaths is the same regardless of expected mortality based on age, sex or table rating. cancer- temporary aviation-permanent 2

3 150% of what? Of Expected (all-cause) Mortality for insured lives. 100% likely based on a recent VBT (valuation basic table) representing fully-underwritten industry experience for preferred and standard combined, With adjustment by your pricing actuary for your market and und. approach factoring in anticipated mortality improvements. How well does the researchreference pool match the standard insurance applicant? Does the relative or extra risk shown in a research paper translate into similar (or higher or lower) extra risk: When applied to an applicant ref. pool which may be healthier? When applied to a diseased pool which may be healthier? 3

4 Distribution of applicants Usually 85 to 95% will be standard or preferred depending on age and market (may be lower for some markets). Distribution of offers across preferred classes? Know your product targets. To be equal across age and sex? When changing the ratings for any finding, the distributions across preferred classes, standard and substandard must be recognized and probably maintained. Shift roughly same # up as down; no credit without a debit. 4

5 Statistical evaluation There are 3 kinds of lies: lies, damned lies and statistics. Disraeli Statistics can help us make use of real world data to draw meaningful conclusions. They can be used to determine if results seen likely reflect TRUTH (or just confuse the reader into believing something not true). The % of published conclusions that are accurate has been questioned. Use to the minimum extent needed. Beware conclusions which can only be reached by statistics that you can t begin to understand or articles dominated by statistical verbiage. 5

6 Life table analysis Often used for pools of insured lives (or similar) and a wellsuited, easily understood tool for that. Splits done by durations of follow-up after underwriting accounting for varying degree of selection. Compare actual to expected mortality often based on external mortality table such as VBT. Difficult to identify comparable reference pool for non-insur. studies. For insur. life studies, just being insured for an impairment (MIB code) may mean highly selected cases. Univariate, runs low on outcomes in each cell (30) and often requires separate expected mortality pool. Usually limited to insured lives (or similar data) and very large data-sets. 6

7 Survival by duration but univariate (ignores maldistribution of other factors). Great for comparing treatments or single findings when disease associated mortality much higher than other causes and when relative risk may vary between groups over time. Kaplan Meier Plot 7

8 ROC Curve A simple (simplistic) graphical tool to evaluate how well any test result predicts the presence (sensitivity) and absence (specificity) of a condition or the risk of an event. Generates a graph and an AUC (area under the curve) identical to the c statistic. No association has AUC of 0.5; perfect association is 1.0 (or 0.0 if the association is negative). A univariate analysis requiring care that the association is not really based on other, not-included, variables such as age and sex. 8

9 ROC- which test is better? Men age AUC Urine albumin.641 Urine p/c.658 Applicants tested at CRL , VS in

10 ROC- value of unrelated tests? Women age Applicants tested at CRL , VS in

11 ROC- Test values Women age Chol/HDL Sensitivity 1- Specificity

12 Cox regression analysis The most common analysis seen in medical journals. Uses a regression algorithm to determine how well a finding A explains results B - not cause and effect! It allows use of data the way it is available in the real world by adjusting for rather than spitting by (or ignoring): Different periods of follow-up for subjects. A range of ages and both sexes accounting for the mortality impact of those variables.. Other differences between subjects that may impact outcome such as smoking, stage, grade or laboratory test results. 12

13 Why Cox is so valuable Generates a multivariate analysis. You can keep all the (limited) data together in the analysis rather than splitting by age, sex or duration so you don t have too few outcomes (the bane of any medical researcher s existence). You can account for the impact of each variable on the outcome. 13

14 How does Cox do it? It uses regression algorithms to assign part of the risk to each variable based on how well each explains the outcome (mortality). It is done with software programs such as SPSS or SAS or Stata which are loaded with the data and then the Cox button is pushed after options chosen. Assumesrelative risk associated with any variable stable over time period considered (proportional hazard assumption) and that variables are independent. 14

15 Outcome- a hazard ratio A hazard ratio (such as 1.45) reflecting the relative risk of an outcome based on: one integer to the next averaged across all values (GGT 100 vs. 101, 102, etc. or by year of age, etc.) or between categories such as male and female or between chosen bands of values against a reference band (GGT <65 (ref.), , 101+) or (as commonly done) between % grouping such as tertiles or quintiles often with the best assigned the risk of 1. 15

16 Cox limitations Failure to include variables that may be actual causes of the risk. Not capable of accurately sorting the risk between variables that are dependent or closely related such as HbA1c and fructosamine, or ALT and AST, or ALT and HBV. Include just one test of each thing. Other approaches to deal with the interaction. Lumping subjects together by including as a covariate (age and sex) masks potentially very different results. Assumption that RR stable over time if not. 16

17 Accounting for important variables Haz. Ratio 95% CI for Haz. Ratio Lower Upper CHOLESTEROL CHOLESTEROL SEX AGE The distribution of cholesterol values (mg/dl) will vary by age and sex with the lowest values in young females who will also have the lowest mortality. Adding age and sex as variables to figure out how much of the risk is for cholesterol vs. age or sex. Applicants tested at CRL with VS in

18 Same test, different pop. & view Ingle D, ON THE RISK vol29 n.1 (March, 2013) 18

19 Impact on group vs. subgroup GGT (& age-sex) by Cox 100 Applicants aged tested at CRL, VS 2011, with all other LFTs <95 th % Debits GGT Values (U/L) 19

20 Impact on group vs. subgroup GGT (& age-sex) by Cox All F M Debits GGT Values (U/L) 20

21 Confidence intervals Along with the hazard ratio, you should see confidence intervals which mostly replace traditional p values. Typically shown are the hazard ratios at the upper and lower end of the 95% CI meaning there is a 95% chance the real risk would lie inside the interval. Width of the 95% CI-largely dependent on # of outcomes (deaths). 30 or more per cell is good. If the 95% CIs overlap, then the hazard is not demonstrated to be different at a 95% significance level. May not actually be different or May have too few deaths and too wide a CI to tell. 21

22 HbA1c study- an example of missing variables, confidence intervals &- Khaw. HbA1c and mortality in the Norfolk study. Ann Intern Med 2004 HbA1c values <5%, 5-5.4%, %, 6-6.4%, etc. Had the following hazard ratios (MRs): < 5% 5-5.4% % 6-6.4% Men Women

23 HbA1c study contd. Missing variables, confidence intervals &- < 5% 5-5.4% % 6-6.4% Men ( ) 1.6 ( ) 1.8 ( ) Women ( ) 1.3 ( ) 1.6 ( ) Wide overlapping CIs (based on deaths/cell). plausible but limited support. Included only age as covariate with sex split in their main result table. differences in smoking ( %) and CV risk factors included only in a secondary analysis. 23

24 Assessing an article Did the (Cox) multivariate analysis: Compare meaningful groups or just extreme quintiles) designed to obtain a positive publishable result? Have CIs that support the conclusion? Include all important variables or at least discuss the issue? Include collinear variables (travel together) without discussion? Did the ROC curve ignore an important variable that may also be associated with both high and low results and the outcome of concern? Are the results biologically plausible and meaningful regardless of analysis and statistical methodology? 24

25 Translating research to ratings Associating low albumin with mortality What is the distribution of albumin results? Are there differences by age-sex? = Distribution When does risk go up? Does it vary by age-sex? = Alert value When does risk go up when other findings (only those which would be actually rated ) are accounted for? = Relative Risk or Underwriting action point CRL tested applicants split by sex and age 60 using Cox including age and smoking as covariates- AHOU 2015 and in press based on applicants tested 91 to 2007 at CRL with VS in

26 Distribution of lowalbumin Females Males Albumin g/dl <= % 0.3% 0.1% 0.2% Deaths 283 (29) >3.3 to % 0.6% 0.1% 0.3% >3.5 to % 0.9% 0.1% 0.4% >3.7 to % 5.2% 0.5% 2.7% >3.9 to % 14.5% 2.7% 9.7% >4.0 to % 11.5% 3.7% 9.4% >4.1 to % 13.6% 6.3% 12.4% > % 53.4% 86.5% 64.9% Appropriate reference pool? (not just highest or lowest quintile/decile) Sufficient # (accurate results) or % (useful) in each band? 26

27 Accounting for other variables-smoking Females Males Albumin g/dl <= % 9.0% >3.3 to % 13.1% >3.5 to % 14.8% >3.7 to % 17.8% >3.9 to % 16.9% >4.0 to % 15.7% >4.1 to % 14.8% > % 12.4% Split by sex and age band but use age and smoking as covariables. Account for other test results (low chol, etc.) by excluding cases with other abnormal. Get a speculative idea of risk by adding as covariable rather than excluding. 27

28 Relative Risk by Cox Males age 20-59, relative risk compared to albumin >4.2 All, with age and sex as covariates Include other lab score as variable Exclude those with other lab with high score MR MR MR 95% CI Albumin g/dl (Cox) (Cox) (Cox) Lower Upper <= >3.3 to >3.5 to >3.7 to >3.9 to >4.1 to >4.2 (ref)

29 Same data shown graphically Mortality ratios (Cox) for albumin, Males 20 to 59 Mortality Ratio Albumin Albumin adj for other tests Albumin w/ other tests OK >4.2 (ref) >4.1 to 4.2 >3.9 to 4.1 >3.7 to 3.9 >3.5 to 3.7 >3.3 to 3.5 <=3.3 Albumin (g/dl) 29

30 Low Albumin Rating Create alert values based on increased risk regardless of other findings (for each age-sex quadrant) taking into account distribution (can only review <10% or 5% or fewer). Combine age-sex if close enough to simplify for alert purposes. Create a rating (or other action) point when no other findings/explanation (or in conjunction with other findings). Establish relationship of study pool to standard insurance pool. If substandard results, can only impact a very small percentage. If percentage high, adjust standard cut-off downward and use as a preferred factor instead or in addition to rating. 30

31 Further Discussion or Cases 31

32 Case 1 Your boss suggests it is OK to take diabetics standard if otherwise standard. She based this on a published, well-done industry life table analysis using MIB coding with 15,292 person years of exposure and 71 deaths (expected 55 based on 2001 VBT) noting the MR was only 128% with a 95% CI from %. Your standard class accepts up to 135% risks. Is she correct? How likely from the model is the MR actually 128%? What data should I look at to tell? Is adding a pool of 128% risks OK for standard? Mortality Study of Policies, Milano AF, et al. JIM 2005;37. Is this 128% reflective of the risk of those presenting with DM who are otherwise standard? 32

33 Case 2 The table contains AUCs from a ROC curve for prediction of mortality by egfrusing Rule and CKD-EPI formulas and creatinine. What does it tell us about relative efficacy of each in predicting mortality risk and why is creatinine inverted? Females, age Males, age egfrby Rule egfr by CKD-EPI Creatinine (1/creat.) Which egfrcalc, Fulks M, et al. OTR2015;31. 33

34 Case 3 The table contains RR by Cox for globulin values in males age with age as a covariate. The 2 nd analysis restricts the group to those with <25 debits for BMI, albumin or Alk. Phos. Why are the RRs lower for the 2 nd analysis? Which value might be better for underwriting alert & for und. action? Mortality, all cases Mortality when BMI, albumin, AP <=125% Globulin MR 95% CI MR* 95% CI g/dl (Cox) Lower Upper (Cox) Lower Upper (ref) Serum globulin, Fulks M, et al. JIM 2014;44. 34

Scoring Life Insurance Applicants Laboratory Results, Blood Pressure and Build to Predict All-Cause Mortality Risk

Scoring Life Insurance Applicants Laboratory Results, Blood Pressure and Build to Predict All-Cause Mortality Risk Copyright E 2012 Journal of Insurance Medicine J Insur Med 2012;43:169 177 MORTALITY Scoring Life Insurance Applicants Laboratory Results, Blood Pressure and Build to Predict All-Cause Mortality Risk Michael

More information

Actuaries Club of the Southwest

Actuaries Club of the Southwest Actuaries Club of the Southwest Friday 06/16/2017 Greater Insights. Better Outcomes. 1 Key issues in simplified issue products. The prevalence of risk factors in blood, urine and saliva samples. Robert

More information

Two-Way Independent ANOVA

Two-Way Independent ANOVA Two-Way Independent ANOVA Analysis of Variance (ANOVA) a common and robust statistical test that you can use to compare the mean scores collected from different conditions or groups in an experiment. There

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Wanner C, Inzucchi SE, Lachin JM, et al. Empagliflozin and

More information

Journal of Insurance Medicine Official Journal of the American Academy of Insurance Medicine

Journal of Insurance Medicine Official Journal of the American Academy of Insurance Medicine Journal of Insurance Medicine Official Journal of the American Academy of Insurance Medicine Mortality Associated with Bilirubin Levels in Insurance Applicants Michael Fulks, MD; Robert L. Stout, PhD;

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Tangri N, Stevens LA, Griffith J, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011;305(15):1553-1559. eequation. Applying the

More information

ESM1 for Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study

ESM1 for Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study ESM1 for Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study Statistical modelling details We used Cox proportional-hazards

More information

Diagnostic methods 2: receiver operating characteristic (ROC) curves

Diagnostic methods 2: receiver operating characteristic (ROC) curves abc of epidemiology http://www.kidney-international.org & 29 International Society of Nephrology Diagnostic methods 2: receiver operating characteristic (ROC) curves Giovanni Tripepi 1, Kitty J. Jager

More information

Chapter 1: CKD in the General Population

Chapter 1: CKD in the General Population Chapter 1: CKD in the General Population Overall prevalence of CKD (Stages 1-5) in the U.S. adult general population was 14.8% in 2011-2014. CKD Stage 3 is the most prevalent (NHANES: Figure 1.2 and Table

More information

DIABETES AND LABORATORY TESTS. Author: Josephine Davis

DIABETES AND LABORATORY TESTS. Author: Josephine Davis DIABETES AND LABORATORY TESTS Author: Josephine Davis LAB TESTS Think twice before you test. What is the reason for testing? Laboratory tests are generally requested in primary care for one of the following

More information

Central pressures and prediction of cardiovascular events in erectile dysfunction patients

Central pressures and prediction of cardiovascular events in erectile dysfunction patients Central pressures and prediction of cardiovascular events in erectile dysfunction patients N. Ioakeimidis, K. Rokkas, A. Angelis, Z. Kratiras, M. Abdelrasoul, C. Georgakopoulos, D. Terentes-Printzios,

More information

Stratified Cost-Effectiveness Analysis (with implications for sub-group analysis) (and applications to value-based pricing)

Stratified Cost-Effectiveness Analysis (with implications for sub-group analysis) (and applications to value-based pricing) Stratified Cost-Effectiveness Analysis (with implications for sub-group analysis) (and applications to value-based pricing) Andrew H Briggs William R Lindsay Chair of Health Economics Stratified CEA: Overview

More information

SUPPLEMENTARY DATA. Supplementary Figure S1. Cohort definition flow chart.

SUPPLEMENTARY DATA. Supplementary Figure S1. Cohort definition flow chart. Supplementary Figure S1. Cohort definition flow chart. Supplementary Table S1. Baseline characteristics of study population grouped according to having developed incident CKD during the follow-up or not

More information

Schöttker et al. BMC Medicine (2016) 14:26 DOI /s

Schöttker et al. BMC Medicine (2016) 14:26 DOI /s Schöttker et al. BMC Medicine (2016) 14:26 DOI 10.1186/s12916-016-0570-1 RESEARCH ARTICLE HbA 1c levels in non-diabetic older adults No J-shaped associations with primary cardiovascular events, cardiovascular

More information

Aetiology versus Prediction - correct for Confounding? Friedo Dekker ERA-EDTA Registry / LUMC

Aetiology versus Prediction - correct for Confounding? Friedo Dekker ERA-EDTA Registry / LUMC Aetiology versus Prediction - correct for Confounding? Friedo Dekker ERA-EDTA Registry / LUMC Aetiology Study effect of a risk factor on an outcome Consider potential confounding: other risk factor for

More information

CHL 5225 H Advanced Statistical Methods for Clinical Trials. CHL 5225 H The Language of Clinical Trials

CHL 5225 H Advanced Statistical Methods for Clinical Trials. CHL 5225 H The Language of Clinical Trials CHL 5225 H Advanced Statistical Methods for Clinical Trials Two sources for course material 1. Electronic blackboard required readings 2. www.andywillan.com/chl5225h code of conduct course outline schedule

More information

CHAPTER ONE CORRELATION

CHAPTER ONE CORRELATION CHAPTER ONE CORRELATION 1.0 Introduction The first chapter focuses on the nature of statistical data of correlation. The aim of the series of exercises is to ensure the students are able to use SPSS to

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Leibowitz M, Karpati T, Cohen-Stavi CJ, et al. Association between achieved low-density lipoprotein levels and major adverse cardiac events in patients with stable ischemic

More information

Chapter 2: Identification and Care of Patients With CKD

Chapter 2: Identification and Care of Patients With CKD Chapter 2: Identification and Care of Patients With CKD Over half of patients in the Medicare 5% sample (aged 65 and older) had at least one of three diagnosed chronic conditions chronic kidney disease

More information

Addressing error in laboratory biomarker studies

Addressing error in laboratory biomarker studies Addressing error in laboratory biomarker studies Elizabeth Selvin, PhD, MPH Associate Professor of Epidemiology and Medicine Co-Director, Biomarkers and Diagnostic Testing Translational Research Community

More information

Folland et al Chapter 4

Folland et al Chapter 4 Folland et al Chapter 4 Chris Auld Economics 317 January 11, 2011 Chapter 2. We won t discuss, but you should already know: PPF. Supply and demand. Theory of the consumer (indifference curves etc) Theory

More information

Lucia Cea Soriano 1, Saga Johansson 2, Bergur Stefansson 2 and Luis A García Rodríguez 1*

Lucia Cea Soriano 1, Saga Johansson 2, Bergur Stefansson 2 and Luis A García Rodríguez 1* Cea Soriano et al. Cardiovascular Diabetology (2015) 14:38 DOI 10.1186/s12933-015-0204-5 CARDIO VASCULAR DIABETOLOGY ORIGINAL INVESTIGATION Open Access Cardiovascular events and all-cause mortality in

More information

Learning Objectives 9/9/2013. Hypothesis Testing. Conflicts of Interest. Descriptive statistics: Numerical methods Measures of Central Tendency

Learning Objectives 9/9/2013. Hypothesis Testing. Conflicts of Interest. Descriptive statistics: Numerical methods Measures of Central Tendency Conflicts of Interest I have no conflict of interest to disclose Biostatistics Kevin M. Sowinski, Pharm.D., FCCP Last-Chance Ambulatory Care Webinar Thursday, September 5, 2013 Learning Objectives For

More information

Chapter Two Renal function measures in the adolescent NHANES population

Chapter Two Renal function measures in the adolescent NHANES population 0 Chapter Two Renal function measures in the adolescent NHANES population In youth acquire that which may restore the damage of old age; and if you are mindful that old age has wisdom for its food, you

More information

9/4/2013. Decision Errors. Hypothesis Testing. Conflicts of Interest. Descriptive statistics: Numerical methods Measures of Central Tendency

9/4/2013. Decision Errors. Hypothesis Testing. Conflicts of Interest. Descriptive statistics: Numerical methods Measures of Central Tendency Conflicts of Interest I have no conflict of interest to disclose Biostatistics Kevin M. Sowinski, Pharm.D., FCCP Pharmacotherapy Webinar Review Course Tuesday, September 3, 2013 Descriptive statistics:

More information

An Update & Suggestions on How to Use It

An Update & Suggestions on How to Use It Information as of November 2014 NT-proBNP NT-proBNP may be used to help detect, diagnose and evaluate the severity of heart failure. An Update & Suggestions on How to Use It ExamOne s NT-proBNP Experience

More information

Types of data and how they can be analysed

Types of data and how they can be analysed 1. Types of data British Standards Institution Study Day Types of data and how they can be analysed Martin Bland Prof. of Health Statistics University of York http://martinbland.co.uk In this lecture we

More information

USING STATCRUNCH TO CONSTRUCT CONFIDENCE INTERVALS and CALCULATE SAMPLE SIZE

USING STATCRUNCH TO CONSTRUCT CONFIDENCE INTERVALS and CALCULATE SAMPLE SIZE USING STATCRUNCH TO CONSTRUCT CONFIDENCE INTERVALS and CALCULATE SAMPLE SIZE Using StatCrunch for confidence intervals (CI s) is super easy. As you can see in the assignments, I cover 9.2 before 9.1 because

More information

Live WebEx meeting agenda

Live WebEx meeting agenda 10:00am 10:30am Using OpenMeta[Analyst] to extract quantitative data from published literature Live WebEx meeting agenda August 25, 10:00am-12:00pm ET 10:30am 11:20am Lecture (this will be recorded) 11:20am

More information

Making comparisons. Previous sessions looked at how to describe a single group of subjects However, we are often interested in comparing two groups

Making comparisons. Previous sessions looked at how to describe a single group of subjects However, we are often interested in comparing two groups Making comparisons Previous sessions looked at how to describe a single group of subjects However, we are often interested in comparing two groups Data can be interpreted using the following fundamental

More information

IAPT: Regression. Regression analyses

IAPT: Regression. Regression analyses Regression analyses IAPT: Regression Regression is the rather strange name given to a set of methods for predicting one variable from another. The data shown in Table 1 and come from a student project

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Serra AL, Poster D, Kistler AD, et al. Sirolimus and kidney

More information

Chapter 14: More Powerful Statistical Methods

Chapter 14: More Powerful Statistical Methods Chapter 14: More Powerful Statistical Methods Most questions will be on correlation and regression analysis, but I would like you to know just basically what cluster analysis, factor analysis, and conjoint

More information

Trends in Insurance Lab Testing

Trends in Insurance Lab Testing Trends in Insurance Lab Testing Moderated By: Gerri Bishop CDT Lisa Goldsmith Protective Case Study For CDT Female age 70, trial for $2,100,000 Aps: 12/08 SGOT 161, SGPT 200 1/09 SGOT 100, SGPT 124 4/09

More information

Your Task: Find a ZIP code in Seattle where the crime rate is worse than you would expect and better than you would expect.

Your Task: Find a ZIP code in Seattle where the crime rate is worse than you would expect and better than you would expect. Forensic Geography Lab: Regression Part 1 Payday Lending and Crime Seattle, Washington Background Regression analyses are in many ways the Gold Standard among analytic techniques for undergraduates (and

More information

Authorised: JSWoodford, Lead of Speciality. Biochemistry Reference Intervals, October Page 1 of 5

Authorised: JSWoodford, Lead of Speciality. Biochemistry Reference Intervals, October Page 1 of 5 AFP All All < 15 ug/l Albumin All 0-3M 25-40 g/l Albumin All 3-12M 32-45 g/l Albumin All 1-70Y 34-48 g/l Albumin All >70Y 32-46 g/l Alk Phos All 0-10Y 80-350 U/L Alk Phos M 10-14Y 45-400 U/L Alk Phos F

More information

Haemodiafiltration - the case against. Prof Peter G Kerr Professor/Director of Nephrology Monash Health

Haemodiafiltration - the case against. Prof Peter G Kerr Professor/Director of Nephrology Monash Health Haemodiafiltration - the case against Prof Peter G Kerr Professor/Director of Nephrology Monash Health Know your opposition.. Haemodiafiltration NB: pre or post-dilution What is HDF how is it different

More information

BIOL 458 BIOMETRY Lab 7 Multi-Factor ANOVA

BIOL 458 BIOMETRY Lab 7 Multi-Factor ANOVA BIOL 458 BIOMETRY Lab 7 Multi-Factor ANOVA PART 1: Introduction to Factorial ANOVA ingle factor or One - Way Analysis of Variance can be used to test the null hypothesis that k or more treatment or group

More information

Clinical research in AKI Timing of initiation of dialysis in AKI

Clinical research in AKI Timing of initiation of dialysis in AKI Clinical research in AKI Timing of initiation of dialysis in AKI Josée Bouchard, MD Krescent Workshop December 10 th, 2011 1 Acute kidney injury in ICU 15 25% of critically ill patients experience AKI

More information

Introduction to SPSS S0

Introduction to SPSS S0 Basic medical statistics for clinical and experimental research Introduction to SPSS S0 Katarzyna Jóźwiak k.jozwiak@nki.nl November 10, 2017 1/55 Introduction SPSS = Statistical Package for the Social

More information

Since 1980, obesity has more than doubled worldwide, and in 2008 over 1.5 billion adults aged 20 years were overweight.

Since 1980, obesity has more than doubled worldwide, and in 2008 over 1.5 billion adults aged 20 years were overweight. Impact of metabolic comorbidity on the association between body mass index and health-related quality of life: a Scotland-wide cross-sectional study of 5,608 participants Dr. Zia Ul Haq Doctoral Research

More information

Preliminary Report on Simple Statistical Tests (t-tests and bivariate correlations)

Preliminary Report on Simple Statistical Tests (t-tests and bivariate correlations) Preliminary Report on Simple Statistical Tests (t-tests and bivariate correlations) After receiving my comments on the preliminary reports of your datasets, the next step for the groups is to complete

More information

ARIC Manuscript Proposal # 1518

ARIC Manuscript Proposal # 1518 ARIC Manuscript Proposal # 1518 PC Reviewed: 5/12/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1. a. Full Title: Prevalence of kidney stones and incidence of kidney stone hospitalization in

More information

Alcohol and substance misuse: objectives

Alcohol and substance misuse: objectives AAIM 2012 WS J: Alcohol & substance misuse Robert Coates MD Marianne Cumming MD Joseph Huguenard MD Alcohol and substance misuse: objectives Detection and mortality risk assessment of alcohol and substance

More information

Lecture Outline. Biost 590: Statistical Consulting. Stages of Scientific Studies. Scientific Method

Lecture Outline. Biost 590: Statistical Consulting. Stages of Scientific Studies. Scientific Method Biost 590: Statistical Consulting Statistical Classification of Scientific Studies; Approach to Consulting Lecture Outline Statistical Classification of Scientific Studies Statistical Tasks Approach to

More information

Graphical Exploration of Statistical Interactions. Nick Jackson University of Southern California Department of Psychology 10/25/2013

Graphical Exploration of Statistical Interactions. Nick Jackson University of Southern California Department of Psychology 10/25/2013 Graphical Exploration of Statistical Interactions Nick Jackson University of Southern California Department of Psychology 10/25/2013 1 Overview What is Interaction? 2-Way Interactions Categorical X Categorical

More information

GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS

GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS Table of Contents List of authors pag 2 Supplemental figure I pag 3 Supplemental figure II pag 4 Supplemental

More information

The Risk Study. A prospective, multi-centre, evaluation of an AKI risk prediction tool for emergency hospital admissions

The Risk Study. A prospective, multi-centre, evaluation of an AKI risk prediction tool for emergency hospital admissions The Risk Study A prospective, multi-centre, evaluation of an AKI risk prediction tool for emergency hospital admissions Disclosures Research Funding Commercial Trials Honorarium/Travel Astute Medical SBRI/D4D

More information

The Effect of Patient Neighbourhood Income Level on the Purchase of Continuous Positive Airway

The Effect of Patient Neighbourhood Income Level on the Purchase of Continuous Positive Airway Online Data Supplement The Effect of Patient Neighbourhood Income Level on the Purchase of Continuous Positive Airway Pressure Treatment among Sleep Apnea Patients Tetyana Kendzerska, MD, PhD, Andrea S.

More information

AN INDEPENDENT VALIDATION OF QRISK ON THE THIN DATABASE

AN INDEPENDENT VALIDATION OF QRISK ON THE THIN DATABASE AN INDEPENDENT VALIDATION OF QRISK ON THE THIN DATABASE Dr Gary S. Collins Professor Douglas G. Altman Centre for Statistics in Medicine University of Oxford TABLE OF CONTENTS LIST OF TABLES... 3 LIST

More information

The truth about lying

The truth about lying Reading Practice The truth about lying Over the years Richard Wiseman has tried to unravel the truth about deception - investigating the signs that give away a liar. A In the 1970s, as part of a large-scale

More information

MODEL I: DRINK REGRESSED ON GPA & MALE, WITHOUT CENTERING

MODEL I: DRINK REGRESSED ON GPA & MALE, WITHOUT CENTERING Interpreting Interaction Effects; Interaction Effects and Centering Richard Williams, University of Notre Dame, https://www3.nd.edu/~rwilliam/ Last revised February 20, 2015 Models with interaction effects

More information

Sample Exam Paper Answer Guide

Sample Exam Paper Answer Guide Sample Exam Paper Answer Guide Notes This handout provides perfect answers to the sample exam paper. I would not expect you to be able to produce such perfect answers in an exam. So, use this document

More information

Chapter 8: Calcium, Phosphate and Parathyroid Hormone. Harmonisation of laboratory data between hospitals

Chapter 8: Calcium, Phosphate and Parathyroid Hormone. Harmonisation of laboratory data between hospitals hapter 8: alcium, hosphate and arathyroid ormone verview of presentation n the following section the figures use a common modified box-plot format with data presented separately for haemodialysis and peritoneal

More information

17/10/2012. Could a persistent cough be whooping cough? Epidemiology and Statistics Module Lecture 3. Sandra Eldridge

17/10/2012. Could a persistent cough be whooping cough? Epidemiology and Statistics Module Lecture 3. Sandra Eldridge Could a persistent be whooping? Epidemiology and Statistics Module Lecture 3 Sandra Eldridge Aims of lecture To explain how to interpret a confidence interval To explain the different ways of comparing

More information

Results & Statistics: Description and Correlation. I. Scales of Measurement A Review

Results & Statistics: Description and Correlation. I. Scales of Measurement A Review Results & Statistics: Description and Correlation The description and presentation of results involves a number of topics. These include scales of measurement, descriptive statistics used to summarize

More information

(an intro to AP Biology)

(an intro to AP Biology) (an intro to AP Biology) 1. How does being science literate benefit you and your community? 2. What is the most critical element in the process of doing science? 3. What is meant by the phrase the fuel

More information

Supplemental Table S2: Subgroup analysis for IL-6 with BMI in 3 groups

Supplemental Table S2: Subgroup analysis for IL-6 with BMI in 3 groups Supplemental Table S1: Unadjusted and Adjusted Hazard Ratios for Diabetes Associated with Baseline Factors Considered in Model 3 SMART Participants Only Unadjusted Adjusted* Baseline p-value p-value Covariate

More information

Biostatistics II

Biostatistics II Biostatistics II 514-5509 Course Description: Modern multivariable statistical analysis based on the concept of generalized linear models. Includes linear, logistic, and Poisson regression, survival analysis,

More information

The Whats and Hows of Reference Intervals. Graham Jones Department of Chemical Pathology St Vincent s Hospital, Sydney

The Whats and Hows of Reference Intervals. Graham Jones Department of Chemical Pathology St Vincent s Hospital, Sydney The Whats and Hows of Reference Intervals Graham Jones Department of Chemical Pathology St Vincent s Hospital, Sydney Surabaya Indonesia 2016 Acknowledgements Reference Intervals - Summary What are they

More information

Have you seen a patient like Elaine *?

Have you seen a patient like Elaine *? (linagliptin) 5mg tablets Have you seen a patient like Elaine *? *Hypothetical patient profile Elaine * : 60 years old Housewife *Hypothetical patient profile ELAINE*: T2D Patient with early signs of kidney

More information

One-Way Independent ANOVA

One-Way Independent ANOVA One-Way Independent ANOVA Analysis of Variance (ANOVA) is a common and robust statistical test that you can use to compare the mean scores collected from different conditions or groups in an experiment.

More information

USRDS UNITED STATES RENAL DATA SYSTEM

USRDS UNITED STATES RENAL DATA SYSTEM USRDS UNITED STATES RENAL DATA SYSTEM Chapter 2: Identification and Care of Patients With CKD Over half of patients from the Medicare 5 percent sample have either a diagnosis of chronic kidney disease

More information

Cardiovascular Risk Reduction in Kidney Transplant Recipients

Cardiovascular Risk Reduction in Kidney Transplant Recipients Cardiovascular Risk Reduction in Kidney Transplant Recipients Rainer Oberbauer R.O. AUG 2010 CV Mortality in ESRD compared to the general population R.O.2/32 Modified from Foley et al. AJKD 32 (suppl3):

More information

Take-Home Exam Distributed: October 16, 2013, at 1:30 p.m. Due: October 21, 2013, at 10:00 a.m.

Take-Home Exam Distributed: October 16, 2013, at 1:30 p.m. Due: October 21, 2013, at 10:00 a.m. 20.201 Take-Home Exam Distributed: October 16, 2013, at 1:30 p.m. Due: October 21, 2013, at 10:00 a.m. Directions: This take-home exam is to be completed without help from any other individual except:

More information

Impact of Proposed HRI s on Laboratory Report Flagging Rates

Impact of Proposed HRI s on Laboratory Report Flagging Rates Impact of Proposed HRI s on Laboratory Report Flagging Rates A/Prof. Ken Sikaris Melbourne Pathology BSc(Hons), MBBS, FRCPA, FAACB, FFSc CBN 2011 WORKSHOP 2012 WORKSHOP 2013 WORKSHOP 2014 GENERAL CONCEPTS

More information

BIOSTATISTICAL METHODS

BIOSTATISTICAL METHODS BIOSTATISTICAL METHODS FOR TRANSLATIONAL & CLINICAL RESEARCH PROPENSITY SCORE Confounding Definition: A situation in which the effect or association between an exposure (a predictor or risk factor) and

More information

Chapter 2: Identification and Care of Patients with CKD

Chapter 2: Identification and Care of Patients with CKD Chapter 2: Identification and Care of Patients with CKD Over half of patients in the Medicare 5% sample (aged 65 and older) had at least one of three diagnosed chronic conditions chronic kidney disease

More information

Discovering Meaningful Cut-points to Predict High HbA1c Variation

Discovering Meaningful Cut-points to Predict High HbA1c Variation Proceedings of the 7th INFORMS Workshop on Data Mining and Health Informatics (DM-HI 202) H. Yang, D. Zeng, O. E. Kundakcioglu, eds. Discovering Meaningful Cut-points to Predict High HbAc Variation Si-Chi

More information

(C) Jamalludin Ab Rahman

(C) Jamalludin Ab Rahman SPSS Note The GLM Multivariate procedure is based on the General Linear Model procedure, in which factors and covariates are assumed to have a linear relationship to the dependent variable. Factors. Categorical

More information

egfr > 50 (n = 13,916)

egfr > 50 (n = 13,916) Saxagliptin and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Moderate or Severe Renal Impairment: Observations from the SAVOR-TIMI 53 Trial Supplementary Table 1. Characteristics according

More information

National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation Annual Progress Report: 2009 Formula Grant

National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation Annual Progress Report: 2009 Formula Grant National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation Annual Progress Report: 2009 Formula Grant Reporting Period July 1, 2011 June 30, 2012 Formula Grant Overview The National Surgical

More information

Sepsis. National Clinical Guideline Centre. Sepsis: the recognition, diagnosis and management of sepsis. NICE guideline <number> January 2016

Sepsis. National Clinical Guideline Centre. Sepsis: the recognition, diagnosis and management of sepsis. NICE guideline <number> January 2016 National Clinical Guideline Centre Consultation Sepsis Sepsis: the recognition, diagnosis and management of sepsis NICE guideline Appendices I-O January 2016 Draft for consultation Commissioned

More information

AGING KIDNEY IN HIV DISEASE

AGING KIDNEY IN HIV DISEASE AGING KIDNEY IN HIV DISEASE Michael G. Shlipak, MD, MPH Professor of Medicine, Epidemiology and Biostatistics, UCSF Chief, General Internal Medicine, San Francisco VA Medical Center Kidney, Aging and HIV

More information

Summary. 20 May 2014 EMA/CHMP/SAWP/298348/2014 Procedure No.: EMEA/H/SAB/037/1/Q/2013/SME Product Development Scientific Support Department

Summary. 20 May 2014 EMA/CHMP/SAWP/298348/2014 Procedure No.: EMEA/H/SAB/037/1/Q/2013/SME Product Development Scientific Support Department 20 May 2014 EMA/CHMP/SAWP/298348/2014 Procedure No.: EMEA/H/SAB/037/1/Q/2013/SME Product Development Scientific Support Department evaluating patients with Autosomal Dominant Polycystic Kidney Disease

More information

NHS Diabetes Prevention Programme (NHS DPP) Non-diabetic hyperglycaemia. Produced by: National Cardiovascular Intelligence Network (NCVIN)

NHS Diabetes Prevention Programme (NHS DPP) Non-diabetic hyperglycaemia. Produced by: National Cardiovascular Intelligence Network (NCVIN) NHS Diabetes Prevention Programme (NHS DPP) Non-diabetic hyperglycaemia Produced by: National Cardiovascular Intelligence Network (NCVIN) Date: August 2015 About Public Health England Public Health England

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Pedersen SB, Langsted A, Nordestgaard BG. Nonfasting mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis. JAMA Intern Med. Published online November 7, 2016.

More information

Statistical Methods for the Evaluation of Treatment Effectiveness in the Presence of Competing Risks

Statistical Methods for the Evaluation of Treatment Effectiveness in the Presence of Competing Risks Statistical Methods for the Evaluation of Treatment Effectiveness in the Presence of Competing Risks Ravi Varadhan Assistant Professor (On Behalf of the Johns Hopkins DEcIDE Center) Center on Aging and

More information

Increased Mortality Associated with Elevated Carcinoembryonic Antigen in Insurance Applicants

Increased Mortality Associated with Elevated Carcinoembryonic Antigen in Insurance Applicants Copyright E 2007 Journal of Insurance Medicine J Insur Med 2007;39:251 258 MORTALITY Increased Mortality Associated with Elevated Carcinoembryonic Antigen in Insurance Applicants Robert L. Stout, PhD;

More information

P values From Statistical Design to Analyses to Publication in the Age of Multiplicity

P values From Statistical Design to Analyses to Publication in the Age of Multiplicity P values From Statistical Design to Analyses to Publication in the Age of Multiplicity Ralph B. D Agostino, Sr. PhD Boston University Statistics in Medicine New England Journal of Medicine March 2, 2017

More information

Dr Bill Bartlett Blood Sciences, Ninewells Hospital & Medical School, NHS Tayside, Scotland, UK.

Dr Bill Bartlett Blood Sciences, Ninewells Hospital & Medical School, NHS Tayside, Scotland, UK. Dr Bill Bartlett Blood Sciences, Ninewells Hospital & Medical School, NHS Tayside, Scotland, UK. Bill.Bartlett@nhs.net www.biologicalvariation.com Biological variation affects the clinical utility of reference

More information

2 Assumptions of simple linear regression

2 Assumptions of simple linear regression Simple Linear Regression: Reliability of predictions Richard Buxton. 2008. 1 Introduction We often use regression models to make predictions. In Figure?? (a), we ve fitted a model relating a household

More information

MEDCHEM 570. First Midterm. January 30, 2015

MEDCHEM 570. First Midterm. January 30, 2015 Name MEDCHEM 570 First Midterm January 30, 2015 Instructions: Exam packet totals 7 pages. The last page has a 5 points extra credit question. If you need additional space for a question go to the back

More information

Correlation of novel cardiac marker

Correlation of novel cardiac marker Correlation of novel cardiac marker and mortality in EGAT population. Soluble ST2 hscrp Poh Chanyavanich, MD SukitYamwong, MD Piyamitr Sritara, MD Ramathibodi hospital Background hscrp - the most widely

More information

Student name: SOCI 420 Advanced Methods of Social Research Fall 2017

Student name: SOCI 420 Advanced Methods of Social Research Fall 2017 SOCI 420 Advanced Methods of Social Research Fall 2017 EXAM 1 RUBRIC Instructor: Ernesto F. L. Amaral, Assistant Professor, Department of Sociology Date: October 12, 2017 (Thursday) Section 904: 2:20 3:35pm

More information

Lecture Outline Biost 517 Applied Biostatistics I

Lecture Outline Biost 517 Applied Biostatistics I Lecture Outline Biost 517 Applied Biostatistics I Scott S. Emerson, M.D., Ph.D. Professor of Biostatistics University of Washington Lecture 2: Statistical Classification of Scientific Questions Types of

More information

EXERCISE: HOW TO DO POWER CALCULATIONS IN OPTIMAL DESIGN SOFTWARE

EXERCISE: HOW TO DO POWER CALCULATIONS IN OPTIMAL DESIGN SOFTWARE ...... EXERCISE: HOW TO DO POWER CALCULATIONS IN OPTIMAL DESIGN SOFTWARE TABLE OF CONTENTS 73TKey Vocabulary37T... 1 73TIntroduction37T... 73TUsing the Optimal Design Software37T... 73TEstimating Sample

More information

Meta-Analysis. Zifei Liu. Biological and Agricultural Engineering

Meta-Analysis. Zifei Liu. Biological and Agricultural Engineering Meta-Analysis Zifei Liu What is a meta-analysis; why perform a metaanalysis? How a meta-analysis work some basic concepts and principles Steps of Meta-analysis Cautions on meta-analysis 2 What is Meta-analysis

More information

Title:Identification of a novel microrna signature associated with intrahepatic cholangiocarcinoma (ICC) patient prognosis

Title:Identification of a novel microrna signature associated with intrahepatic cholangiocarcinoma (ICC) patient prognosis Author's response to reviews Title:Identification of a novel microrna signature associated with intrahepatic cholangiocarcinoma (ICC) patient prognosis Authors: Mei-Yin Zhang (zhangmy@sysucc.org.cn) Shu-Hong

More information

UK Liver Transplant Audit

UK Liver Transplant Audit November 2012 UK Liver Transplant Audit In patients who received a Liver Transplant between 1 st March 1994 and 31 st March 2012 ANNUAL REPORT Advisory Group for National Specialised Services Prepared

More information

Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate

Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate BMJ Jenny H Humphreys, Alexander Warner, Ruth Costello, Mark Lunt, Suzanne M M Verstappen,

More information

Types of Statistics. Censored data. Files for today (June 27) Lecture and Homework INTRODUCTION TO BIOSTATISTICS. Today s Outline

Types of Statistics. Censored data. Files for today (June 27) Lecture and Homework INTRODUCTION TO BIOSTATISTICS. Today s Outline INTRODUCTION TO BIOSTATISTICS FOR GRADUATE AND MEDICAL STUDENTS Files for today (June 27) Lecture and Homework Descriptive Statistics and Graphically Visualizing Data Lecture #2 (1 file) PPT presentation

More information

Optimal blood pressure targets in chronic kidney disease

Optimal blood pressure targets in chronic kidney disease Optimal blood pressure targets in chronic kidney disease Pr. Michel Burnier Service of Nephrology and Hypertension University Hospital Lausanne Switzerland Evidence-Based Guideline for the Management

More information

Propensity Score Analysis to compare effects of radiation and surgery on survival time of lung cancer patients from National Cancer Registry (SEER)

Propensity Score Analysis to compare effects of radiation and surgery on survival time of lung cancer patients from National Cancer Registry (SEER) Propensity Score Analysis to compare effects of radiation and surgery on survival time of lung cancer patients from National Cancer Registry (SEER) Yan Wu Advisor: Robert Pruzek Epidemiology and Biostatistics

More information

Understanding Statistics for Research Staff!

Understanding Statistics for Research Staff! Statistics for Dummies? Understanding Statistics for Research Staff! Those of us who DO the research, but not the statistics. Rachel Enriquez, RN PhD Epidemiologist Why do we do Clinical Research? Epidemiology

More information

(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects

(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects Table 1. Distribution of baseline characteristics across tertiles of OPG adjusted for age and sex (n=6279). Continuous variables are reported as mean with 95% confidence interval and categorical values

More information

Hypertension targets: sorting out the confusion. Brian Rayner, Division of Nephrology and Hypertension, University of Cape Town

Hypertension targets: sorting out the confusion. Brian Rayner, Division of Nephrology and Hypertension, University of Cape Town Hypertension targets: sorting out the confusion Brian Rayner, Division of Nephrology and Hypertension, University of Cape Town Historical Perspective The most famous casualty of this approach was the

More information

Cardiovascular Diabetology. Open Access ORIGINAL INVESTIGATION. C. R. L. Cardoso 1, N. C. Leite 1, C. B. M. Moram 2 and G. F.

Cardiovascular Diabetology. Open Access ORIGINAL INVESTIGATION. C. R. L. Cardoso 1, N. C. Leite 1, C. B. M. Moram 2 and G. F. https://doi.org/10.1186/s12933-018-0677-0 Cardiovascular Diabetology ORIGINAL INVESTIGATION Open Access Long term visit to visit glycemic variability as predictor of micro and macrovascular complications

More information

Sample size calculation a quick guide. Ronán Conroy

Sample size calculation a quick guide. Ronán Conroy Sample size calculation a quick guide Thursday 28 October 2004 Ronán Conroy rconroy@rcsi.ie How to use this guide This guide has sample size ready-reckoners for a number of common research designs. Each

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Solomon SD, Uno H, Lewis EF, et al. Erythropoietic response

More information